Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02420379
Recruitment Status : Completed
First Posted : April 17, 2015
Last Update Posted : February 26, 2019
Sponsor:
Information provided by (Responsible Party):
Sarepta Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 17, 2018
  Actual Study Completion Date : December 17, 2018